Quoin Pharmaceuticals Ltd. ADR Company Profile
NASDAQ: QNRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Quoin Pharmaceuticals at a glance
Quoin Pharmaceuticals Ltd. ADR (NASDAQ: QNRX) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Ashburn, VA, Israel. Quoin Pharmaceuticals is led by Dr. Michael Myers Ph.D. and employs about 4 people. The company's shares have traded publicly since 2016.
At a market capitalization of $21.9 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001671502, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Quoin Pharmaceuticals do?
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Business description based on the company's public filings.
Company information
- Legal name
- Quoin Pharmaceuticals Ltd. ADR
- Ticker
- NASDAQ: QNRX
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Michael Myers Ph.D.
- Employees
- 4
- Headquarters
- 42127 Pleasant Forest Court, Ashburn, VA, Israel
- Phone
- 703 980 4182
- Website
- quoinpharma.com
- IPO year
- 2016
- Market cap
- $21.86M
- SEC CIK
- 0001671502
- Latest annual report
- 10-K · Mar 26, 2026
Companies similar to Quoin Pharmaceuticals
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AYTUAytu BioPharma Inc. | 2.03 | -1.22% | $22.01M | vs QNRX |
| UPCUniverse Pharmaceuticals Inc. Class A | 4.15 | 0.00% | $20.85M | vs QNRX |
| OPTHOptimi Health Corp. | 4.02 | -1.59% | $23.02M | vs QNRX |
| COCPCocrystal Pharma Inc. | 1.07 | 0.00% | $20.61M | vs QNRX |
| AKTXAkari Therapeutics plc ADS | 8.77 | +3.30% | $20.04M | vs QNRX |
| TXMDTherapeuticsMD Inc. | 2.06 | +2.49% | $23.84M | vs QNRX |
| ATOSAtossa Therapeutics Inc. | 2.44 | +0.83% | $24.35M | vs QNRX |
| KYNBKyntra Bio Inc. | 6.11 | +2.52% | $24.74M | vs QNRX |